US HB3810 | 2023-2024 | 118th Congress

Status

Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on June 5 2023 - 25% progression
Action: 2023-06-09 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Drug Origin Transparency Act of 2023

Sponsors


History

DateChamberAction
2023-06-09HouseReferred to the Subcommittee on Health.
2023-06-05HouseReferred to the House Committee on Energy and Commerce.
2023-06-05HouseIntroduced in House

Same As/Similar To

HB4697 (Related) 2023-07-21 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments

feedback